Leaflet MOFIL 400mg film-coated tablets


Indicated for: bacterial infections

Substance: moxifloxacin (fluoroquinolone antibiotic)

ATC: J01MA14 (Antiinfectives for systemic use | Quinolone antibacterials | Fluoroquinolones)

Moxifloxacinum is a fluoroquinolone antibiotic used to treat bacterial infections, including respiratory infections, sinusitis, skin infections, and intra-abdominal infections. It works by inhibiting bacterial enzymes essential for DNA replication, thereby killing the bacteria.

The medication is administered orally or intravenously, depending on the severity of the infection. It is effective against a wide range of bacteria, including strains resistant to other antibiotics.

Side effects may include nausea, diarrhea, dizziness, and, in rare cases, severe reactions such as tendinitis or tendon rupture. It is important to inform your doctor about any side effects or other medications you are taking.

Consult your doctor before use, especially if you have liver, kidney, or other health conditions. Use Moxifloxacinum as directed to prevent the development of bacterial resistance.

General data about MOFIL 400mg

  • Substance: moxifloxacin
  • Date of last drug list: 01-07-2020
  • Commercial code: W60545001
  • Concentration: 400mg
  • Pharmaceutical form: film-coated tablets
  • Quantity: 5
  • Product type: generic
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: PHARMATHEN S.A. - GRECIA
  • Holder: ACTAVIS GROUP PTC EHF. - ISLANDA
  • Number: 6159/2014/01
  • Shelf life: 3 years

Pharmaceutical forms available for moxifloxacin

Concentrations available for moxifloxacin

  • 400mg
  • 400mg/250ml
  • 5mg/ml